Form 4: Eileen McCarthy Reports CHEMED CORP Stock Acquisition

Eileen P. McCarthy, a Director at CHEMED CORP, reported the acquisition of 386 shares of Capital Stock on May 18, 2026.

Summary

• Eileen P. McCarthy, a Director of CHEMED CORP, acquired 386 shares of the company's Capital Stock on May 18, 2026.
• The acquisition was made at a price of $440.77 per share.
• Following this transaction, Ms. McCarthy beneficially owns 1,241 shares of Capital Stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine stock acquisition by a director without additional context on the company's performance or future outlook.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• The acquisition of 386 shares indicates a direct investment by a key insider.

Future Outlook

No specific forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings, like this one from CHEMED CORP, are standard disclosures for insider transactions. Such filings are closely watched by investors for insights into management's confidence in the company's performance.

Stakeholder Impact

• Shareholders may view the director's stock purchase as a positive signal of confidence in the company.

Key Dates

Keywords

CHEMED CORP, Form 4, Insider Trading, Stock Acquisition, Director, Capital Stock, Beneficial Ownership